Mitogen-activated protein kinase inhibition augments the T cell response against HOXB7-expressing tumor through human leukocyte antigen upregulation. 2023

Hiroki Komatsuda, and Risa Wakisaka, and Michihisa Kono, and Takumi Kumai, and Ryusuke Hayashi, and Hidekiyo Yamaki, and Ryosuke Sato, and Toshihiro Nagato, and Takayuki Ohkuri, and Akemi Kosaka, and Kenzo Ohara, and Miki Takahara, and Akihiro Katada, and Hiroya Kobayashi
Department of Otolaryngology-Head and Neck Surgery, Asahikawa Medical University, Asahikawa, Japan.

Homeobox B7 (HOXB7) is a master regulatory gene that regulates cell proliferation and activates oncogenic pathways. Overexpression of HOXB7 correlates with aggressive behavior and poor prognosis in patients with cancer. However, the expression and role of HOXB7 in head and neck squamous cell carcinoma (HNSCC) remain unclear. In this study, we observed that most samples from patients with oropharyngeal cancer and HNSCC expressed HOXB7. As no direct inhibitor has been reported, we identified a potent peptide epitope to target HOXB7-expressing tumors through immune cells. A novel HOXB7-derived peptide epitope (HOXB78-25 ) elicited antigen-specific and tumor-reactive promiscuous CD4+ T cell responses. These CD4+ T cells produced γ-interferon (IFN-γ) and had the direct ability to kill tumors through granzyme B. Notably, downregulation of HOXB7 using siRNA enhanced human leukocyte antigen class II expression on tumor cells by decreasing the phosphorylation of MAPK. Mitogen-activated protein kinase inhibition augmented IFN-γ production by HOXB7-reactive CD4+ T cell responses without decreasing the expression of HOXB7. These results suggest that combining HOXB7 peptide-based vaccine with MAPK inhibitors could be an effective immunological strategy for cancer treatment.

UI MeSH Term Description Entries
D005801 Genes, Homeobox Genes that encode highly conserved TRANSCRIPTION FACTORS that control positional identity of cells (BODY PATTERNING) and MORPHOGENESIS throughout development. Their sequences contain a 180 nucleotide sequence designated the homeobox, so called because mutations of these genes often results in homeotic transformations, in which one body structure replaces another. The proteins encoded by homeobox genes are called HOMEODOMAIN PROTEINS. Genes, Homeotic,Homeobox Sequence,Homeotic Genes,Genes, Homeo Box,Homeo Box,Homeo Box Sequence,Homeo Boxes,Homeobox,Homeoboxes,Hox Genes,Sequence, Homeo Box,Gene, Homeo Box,Gene, Homeobox,Gene, Homeotic,Gene, Hox,Genes, Hox,Homeo Box Gene,Homeo Box Genes,Homeo Box Sequences,Homeobox Gene,Homeobox Genes,Homeobox Sequences,Homeotic Gene,Hox Gene,Sequence, Homeobox,Sequences, Homeo Box,Sequences, Homeobox
D006258 Head and Neck Neoplasms Soft tissue tumors or cancer arising from the mucosal surfaces of the LIP; oral cavity; PHARYNX; LARYNX; and cervical esophagus. Other sites included are the NOSE and PARANASAL SINUSES; SALIVARY GLANDS; THYROID GLAND and PARATHYROID GLANDS; and MELANOMA and non-melanoma skin cancers of the head and neck. (from Holland et al., Cancer Medicine, 4th ed, p1651) Cancer of Head and Neck,Head Cancer,Head Neoplasm,Head and Neck Cancer,Head and Neck Neoplasm,Neck Cancer,Neck Neoplasm,Neck Neoplasms,Neoplasms, Upper Aerodigestive Tract,UADT Neoplasm,Upper Aerodigestive Tract Neoplasm,Upper Aerodigestive Tract Neoplasms,Cancer of Head,Cancer of Neck,Cancer of the Head,Cancer of the Head and Neck,Cancer of the Neck,Head Neoplasms,Head, Neck Neoplasms,Neoplasms, Head,Neoplasms, Head and Neck,Neoplasms, Neck,UADT Neoplasms,Cancer, Head,Cancer, Neck,Cancers, Head,Cancers, Neck,Head Cancers,Neck Cancers,Neoplasm, Head,Neoplasm, Neck,Neoplasm, UADT,Neoplasms, UADT
D006680 HLA Antigens Antigens determined by leukocyte loci found on chromosome 6, the major histocompatibility loci in humans. They are polypeptides or glycoproteins found on most nucleated cells and platelets, determine tissue types for transplantation, and are associated with certain diseases. Human Leukocyte Antigen,Human Leukocyte Antigens,Leukocyte Antigens,HL-A Antigens,Antigen, Human Leukocyte,Antigens, HL-A,Antigens, HLA,Antigens, Human Leukocyte,Antigens, Leukocyte,HL A Antigens,Leukocyte Antigen, Human,Leukocyte Antigens, Human
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000077195 Squamous Cell Carcinoma of Head and Neck The most common type of head and neck carcinoma that originates from cells on the surface of the NASAL CAVITY; MOUTH; PARANASAL SINUSES, SALIVARY GLANDS, and LARYNX. Mutations in TNFRSF10B, PTEN, and ING1 genes are associated with this cancer. HNSCC,Head And Neck Squamous Cell Carcinomas,Hypopharyngeal Squamous Cell Carcinoma,Laryngeal Squamous Cell Carcinoma,Oral Cavity Squamous Cell Carcinoma,Oral Squamous Cell Carcinoma,Oral Squamous Cell Carcinomas,Oral Tongue Squamous Cell Carcinoma,Oropharyngeal Squamous Cell Carcinoma,Squamous Cell Carcinoma of Larynx,Squamous Cell Carcinoma of the Larynx,Squamous Cell Carcinoma of the Mouth,Squamous Cell Carcinoma of the Nasal Cavity,Carcinoma, Squamous Cell of Head and Neck,Head and Neck Squamous Cell Carcinoma,Squamous Cell Carcinoma of the Head and Neck,Squamous Cell Carcinoma, Head And Neck
D000939 Epitopes Sites on an antigen that interact with specific antibodies. Antigenic Determinant,Antigenic Determinants,Antigenic Specificity,Epitope,Determinant, Antigenic,Determinants, Antigenic,Specificity, Antigenic
D000949 Histocompatibility Antigens Class II Large, transmembrane, non-covalently linked glycoproteins (alpha and beta). Both chains can be polymorphic although there is more structural variation in the beta chains. The class II antigens in humans are called HLA-D ANTIGENS and are coded by a gene on chromosome 6. In mice, two genes named IA and IE on chromosome 17 code for the H-2 antigens. The antigens are found on B-lymphocytes, macrophages, epidermal cells, and sperm and are thought to mediate the competence of and cellular cooperation in the immune response. The term IA antigens used to refer only to the proteins encoded by the IA genes in the mouse, but is now used as a generic term for any class II histocompatibility antigen. Antigens, Immune Response,Class II Antigens,Class II Histocompatibility Antigen,Class II Major Histocompatibility Antigen,Ia Antigens,Ia-Like Antigen,Ia-Like Antigens,Immune Response Antigens,Immune-Associated Antigens,Immune-Response-Associated Antigens,MHC Class II Molecule,MHC II Peptide,Class II Antigen,Class II Histocompatibility Antigens,Class II MHC Proteins,Class II Major Histocompatibility Antigens,Class II Major Histocompatibility Molecules,I-A Antigen,I-A-Antigen,IA Antigen,MHC Class II Molecules,MHC II Peptides,MHC-II Molecules,Antigen, Class II,Antigen, I-A,Antigen, IA,Antigen, Ia-Like,Antigens, Class II,Antigens, Ia,Antigens, Ia-Like,Antigens, Immune-Associated,Antigens, Immune-Response-Associated,I A Antigen,II Peptide, MHC,Ia Like Antigen,Ia Like Antigens,Immune Associated Antigens,Immune Response Associated Antigens,MHC II Molecules,Molecules, MHC-II,Peptide, MHC II,Peptides, MHC II
D013601 T-Lymphocytes Lymphocytes responsible for cell-mediated immunity. Two types have been identified - cytotoxic (T-LYMPHOCYTES, CYTOTOXIC) and helper T-lymphocytes (T-LYMPHOCYTES, HELPER-INDUCER). They are formed when lymphocytes circulate through the THYMUS GLAND and differentiate to thymocytes. When exposed to an antigen, they divide rapidly and produce large numbers of new T cells sensitized to that antigen. T Cell,T Lymphocyte,T-Cells,Thymus-Dependent Lymphocytes,Cell, T,Cells, T,Lymphocyte, T,Lymphocyte, Thymus-Dependent,Lymphocytes, T,Lymphocytes, Thymus-Dependent,T Cells,T Lymphocytes,T-Cell,T-Lymphocyte,Thymus Dependent Lymphocytes,Thymus-Dependent Lymphocyte
D015395 Histocompatibility Antigens Class I Membrane glycoproteins consisting of an alpha subunit and a BETA 2-MICROGLOBULIN beta subunit. In humans, highly polymorphic genes on CHROMOSOME 6 encode the alpha subunits of class I antigens and play an important role in determining the serological specificity of the surface antigen. Class I antigens are found on most nucleated cells and are generally detected by their reactivity with alloantisera. These antigens are recognized during GRAFT REJECTION and restrict cell-mediated lysis of virus-infected cells. Class I Antigen,Class I Antigens,Class I Histocompatibility Antigen,Class I MHC Protein,Class I Major Histocompatibility Antigen,MHC Class I Molecule,MHC-I Peptide,Class I Histocompatibility Antigens,Class I Human Antigens,Class I MHC Proteins,Class I Major Histocompatibility Antigens,Class I Major Histocompatibility Molecules,Human Class I Antigens,MHC Class I Molecules,MHC-I Molecules,MHC-I Peptides,Antigen, Class I,Antigens, Class I,I Antigen, Class,MHC I Molecules,MHC I Peptide,MHC I Peptides,Molecules, MHC-I,Peptide, MHC-I,Peptides, MHC-I
D015854 Up-Regulation A positive regulatory effect on physiological processes at the molecular, cellular, or systemic level. At the molecular level, the major regulatory sites include membrane receptors, genes (GENE EXPRESSION REGULATION), mRNAs (RNA, MESSENGER), and proteins. Receptor Up-Regulation,Upregulation,Up-Regulation (Physiology),Up Regulation

Related Publications

Hiroki Komatsuda, and Risa Wakisaka, and Michihisa Kono, and Takumi Kumai, and Ryusuke Hayashi, and Hidekiyo Yamaki, and Ryosuke Sato, and Toshihiro Nagato, and Takayuki Ohkuri, and Akemi Kosaka, and Kenzo Ohara, and Miki Takahara, and Akihiro Katada, and Hiroya Kobayashi
January 1999, Blood,
Hiroki Komatsuda, and Risa Wakisaka, and Michihisa Kono, and Takumi Kumai, and Ryusuke Hayashi, and Hidekiyo Yamaki, and Ryosuke Sato, and Toshihiro Nagato, and Takayuki Ohkuri, and Akemi Kosaka, and Kenzo Ohara, and Miki Takahara, and Akihiro Katada, and Hiroya Kobayashi
February 2001, Infection and immunity,
Hiroki Komatsuda, and Risa Wakisaka, and Michihisa Kono, and Takumi Kumai, and Ryusuke Hayashi, and Hidekiyo Yamaki, and Ryosuke Sato, and Toshihiro Nagato, and Takayuki Ohkuri, and Akemi Kosaka, and Kenzo Ohara, and Miki Takahara, and Akihiro Katada, and Hiroya Kobayashi
October 2014, Cancer science,
Hiroki Komatsuda, and Risa Wakisaka, and Michihisa Kono, and Takumi Kumai, and Ryusuke Hayashi, and Hidekiyo Yamaki, and Ryosuke Sato, and Toshihiro Nagato, and Takayuki Ohkuri, and Akemi Kosaka, and Kenzo Ohara, and Miki Takahara, and Akihiro Katada, and Hiroya Kobayashi
January 2013, Folia neuropathologica,
Hiroki Komatsuda, and Risa Wakisaka, and Michihisa Kono, and Takumi Kumai, and Ryusuke Hayashi, and Hidekiyo Yamaki, and Ryosuke Sato, and Toshihiro Nagato, and Takayuki Ohkuri, and Akemi Kosaka, and Kenzo Ohara, and Miki Takahara, and Akihiro Katada, and Hiroya Kobayashi
November 1999, Journal of immunology (Baltimore, Md. : 1950),
Hiroki Komatsuda, and Risa Wakisaka, and Michihisa Kono, and Takumi Kumai, and Ryusuke Hayashi, and Hidekiyo Yamaki, and Ryosuke Sato, and Toshihiro Nagato, and Takayuki Ohkuri, and Akemi Kosaka, and Kenzo Ohara, and Miki Takahara, and Akihiro Katada, and Hiroya Kobayashi
November 2013, Chinese medical journal,
Hiroki Komatsuda, and Risa Wakisaka, and Michihisa Kono, and Takumi Kumai, and Ryusuke Hayashi, and Hidekiyo Yamaki, and Ryosuke Sato, and Toshihiro Nagato, and Takayuki Ohkuri, and Akemi Kosaka, and Kenzo Ohara, and Miki Takahara, and Akihiro Katada, and Hiroya Kobayashi
November 1998, Pediatric nephrology (Berlin, Germany),
Hiroki Komatsuda, and Risa Wakisaka, and Michihisa Kono, and Takumi Kumai, and Ryusuke Hayashi, and Hidekiyo Yamaki, and Ryosuke Sato, and Toshihiro Nagato, and Takayuki Ohkuri, and Akemi Kosaka, and Kenzo Ohara, and Miki Takahara, and Akihiro Katada, and Hiroya Kobayashi
September 2000, Journal of cellular biochemistry,
Hiroki Komatsuda, and Risa Wakisaka, and Michihisa Kono, and Takumi Kumai, and Ryusuke Hayashi, and Hidekiyo Yamaki, and Ryosuke Sato, and Toshihiro Nagato, and Takayuki Ohkuri, and Akemi Kosaka, and Kenzo Ohara, and Miki Takahara, and Akihiro Katada, and Hiroya Kobayashi
April 2011, Zhonghua fu chan ke za zhi,
Hiroki Komatsuda, and Risa Wakisaka, and Michihisa Kono, and Takumi Kumai, and Ryusuke Hayashi, and Hidekiyo Yamaki, and Ryosuke Sato, and Toshihiro Nagato, and Takayuki Ohkuri, and Akemi Kosaka, and Kenzo Ohara, and Miki Takahara, and Akihiro Katada, and Hiroya Kobayashi
February 1996, European journal of biochemistry,
Copied contents to your clipboard!